Cikkek nyilvánosan hozzáférhető megbízással - Gian Battista ChierchiaTovábbi információ
Sehol sem hozzáférhető: 2
The Importance of Class‐I Antiarrhythmic Drug Test in the Evaluation of Patients with Syncope: Unmasking Brugada Syndrome
M Roos, A Sarkozy, J Brodbeck, S Henkens, GB CHIERCHIA, ...
Journal of cardiovascular electrophysiology 23 (3), 290-295, 2012
Megbízások: Swiss National Science Foundation
High-density mapping in patients undergoing ablation of atrial fibrillation with the fourth-generation cryoballoon and the new spiral mapping catheter
G Conte, K Soejima, C de Asmundis, J Bruno, F Cattaneo, GB Chierchia, ...
EP Europace 22 (11), 1653-1658, 2020
Megbízások: Swiss National Science Foundation
Valahol hozzáférhető: 10
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study
E Ekanem, P Neuzil, T Reichlin, J Kautzner, P van der Voort, P Jais, ...
Nature medicine 30 (7), 2020-2029, 2024
Megbízások: Swiss National Science Foundation, European Commission
Monomorphic ventricular tachycardia in patients with Brugada syndrome: a multicenter retrospective study
M Rodríguez-Mañero, F Sacher, C De Asmundis, P Maury, PD Lambiase, ...
Heart rhythm 13 (3), 669-682, 2016
Megbízások: US National Institutes of Health
Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European observational multicenter study
R Providencia, P Adragão, C de Asmundis, J Chun, G Chierchia, ...
Journal of the American Heart Association 8 (20), e012253, 2019
Megbízások: National Institute for Health Research, UK
Short P‐wave duration is a marker of higher rate of atrial fibrillation recurrences after pulmonary vein isolation: new insights into the pathophysiological mechanisms through …
A Auricchio, T Özkartal, F Salghetti, L Neumann, S Pezzuto, A Gharaviri, ...
Journal of the American Heart Association 10 (2), e018572, 2021
Megbízások: Dutch Heart Foundation
Worse prognosis in Brugada syndrome patients with arrhythmogenic cardiomyopathy features
E Scheirlynck, M Chivulescu, ØH Lie, A Motoc, J Koulalis, C de Asmundis, ...
Clinical Electrophysiology 6 (11), 1353-1363, 2020
Megbízások: Research Council of Norway
Cryoballoon catheter ablation versus antiarrhythmic drugs as a first-line therapy for patients with paroxysmal atrial fibrillation: rationale and design of the international …
JS Hermida, J Chen, C Meyer, S Iacopino, G Arena, N Pavlovic, V Velagic, ...
American heart journal 222, 64-72, 2020
Megbízások: US National Institutes of Health
A critical analysis of the scientific evidence behind international guidelines related to cardiac arrhythmias
M Roos, J Brodbeck, A Sarkozy, G Battista Chierchia, C De Asmundis, ...
Circulation: Arrhythmia and Electrophysiology 4 (2), 202-210, 2011
Megbízások: Swiss National Science Foundation
Characterization and clinical significance of hemolysis after pulsed field ablation for atrial fibrillation: results of a multicenter analysis
MA Popa, S Venier, R Menè, DG Della Rocca, F Sacher, N Derval, ...
Circulation: Arrhythmia and Electrophysiology 17 (10), e012732, 2024
Megbízások: European Commission, Agence Nationale de la Recherche
Catheter ablation of atrial fibrillation in patients with heart failure with reduced ejection fraction: Real world experience from six European centers
R Providencia, C de Asmundis, J Chun, G Chierchia, P Defaye, ...
Journal of Cardiovascular Electrophysiology 30 (8), 1270-1277, 2019
Megbízások: National Institute for Health Research, UK
Long‐term outcomes of pulmonary vein isolation in patients with Brugada syndrome and paroxysmal atrial fibrillation
A Bisignani, G Conte, L Pannone, J Sieira, A Del Monte, F Lipartiti, G Bala, ...
Journal of the American Heart Association 11 (15), e026290, 2022
Megbízások: Swiss National Science Foundation
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.